title: [Tangier-disease (author's transl)].
abstract: Tangier disease is a rare autosomal recessive lipid transport disease characterized by the absence of the usual high density lipoproteins from plasma and cholesteryl ester storage in many organs. 25 cases of Tangier disease have been described so long. The predominant clinical symptoms include tonsilar hypertrophy, splenomegaly and peripheral neuropathy. The cholesteryl ester storage is limited to macrophages, Schwann's cells and intestinal smooth muscle cells. Hypocholest erolemia (less than 80mg/dl), hypertriglyceridemia (greater than 200 mg/dl), and the absence of high density lipoproteins in agarose electrophoresis are the major plasma abnormalities. The protein moiety of normal high density lipoprotein consists of apoprotein A-I and apoprotein A-II. In Tangier disease, serum concentrations of these apoproteins are reduced to less than 1% and 5-10%, respectively. Theories concerning the pathogenesis of Tangier disease are only incomplete and unproved up to now; however, a structural abnormality of apoprotein A-I causing an inability to  bind to lipid or other proteins (apoprotein A-II) is consistent with several of the recent biochemical findings. The imbalance of cellular cholesterol metabolism caused by the absence of high density lipoproteins as well as the presumed role of these lipoproteins in cholesterol removal from cells are discussed in this article.
mesh_terms: D002784:Cholesterol / Q000378:metabolism; D006801:Humans; D007009:Hypolipoproteinemias; D008075:Lipoproteins, HDL / Q000378:metabolism; D013631:Tangier Disease / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism
chemical_list: D008075:Lipoproteins, HDL; D002784:Cholesterol
vernacular_title: Die Tangier Krankheit--Klinik und Pathophysiologie.